.jpg)
.png)
All
.dx { border: 1px Solid Black; padding: 15px; width: 800px; height: 260px; margin: 0; } .dxodd { background-color: #bbc9df; } .dxeven { background-color: #dddbd6; } .dx div:first-child { float: left; width: 190px; height: 300px; } .dx h2... more
Employment Opportunities We invite you to review our job postings to discover opportunities in clinical lipidology and related fields. Members can post a job listing on... more
This issue sponsored by the Southeast Lipid Association Clinical Pedometry—A Brief Overview and Instructions for Healthcare Providers Using Text Messages to Improve Adherence
Familial hypercholesterolemia (FH) is a disease caused by autosomal dominant defects in the genes coding for the lowdensity lipoprotein (LDL) receptor, apolipoprotein (Apo) B, or proprotein convertase subtilisin/kexin type 9 (PCSK9).1 It is the most common single gene lipid disorder. FH is... more
Lipoproteins, Lipids, Cognitive Impairment and Vascular Disease Lipid Luminations
Two new PCSK9 monoclonal antibodies have been given a nod of approval to the Food and Drug Administration (FDA). The FDA Endocrinologic and Metabolic Drugs Advisory Committee reviewed the evidence on the new class of cholesterol-lowering drugs and recommended that the FDA should approve the new... more
h3{ margin-bottom:10px; } Publications Committee The Publications Committee oversees all major publications of the NLA — by suggesting, developing and reviewing all content for message consistency with the mission and goals of the NLA... more
This issue sponsored by the Southeast Lipid Association Featuring: "Translating Clinical Trial Evidence into Practical Medicine" and "Guidelines for the Guidelines — Impact and Controversies" more
James A. Underberg, MD, Elected by NLA Members during the 2016 NLA Scientific Sessions in New Orleans The National Lipid Association (NLA) announces the appointment of James A. Underberg, MD, MS, FACPM, FACP, FASPC, FNLA, as president-elect. NLA members voted on the slate of new nominees during... more
Lipoprotein apheresis is a technique that was first described in 1975. It involves the removal of low-density lipoprotein (LDL) and lipoprotein(a) [Lp(a)] particles from whole blood or plasma. This technique is similar to other apheresis techniques in that the blood is run through a filtering... more